Disease states in addition to hypertension in which beta blockade is a compelling indication
for the use of beta blockers include:
A. Heart failure
B. Angina
C. MI
D. Dyslipidemia
Correct Answer: C. MI
Expert Rationale:
Beta blockers are strongly indicated following a myocardial infarction (MI) because they
decrease myocardial oxygen demand, reduce heart rate and blood pressure, and lower the risk of
reinfarction and sudden cardiac death. Beta blockade improves survival outcomes after MI by
reducing cardiac workload and preventing dysrhythmias.
Option A is incorrect because although certain beta blockers are used in heart failure
management, not all cases of heart failure universally require beta blockade as a primary
compelling indication. Option B is incorrect because beta blockers may be used for angina
symptom control, but MI remains the strongest evidence-based compelling indication in this
question. Option D is incorrect because beta blockers are not first-line agents for dyslipidemia
and may negatively affect lipid profiles in some clients.
NCLEX Focus: Pharmacologic management of cardiovascular disorders.
DIF: Knowledge
REF: Cardiovascular Pharmacology / Beta Blockers
OBJ: Identify compelling indications for beta-blocker therapy
TOP: Pharmacological Therapies
When a patient is on selective-serotonin reuptake inhibitors:
A. The complete blood count must be monitored every three to four months
B. Therapeutic blood levels must be monitored every six months after a steady state is achieved.
,C. Blood glucose must be monitored every three to four months.
D. There is no laboratory monitoring required.
Correct Answer: D. There is no laboratory monitoring required.
Expert Rationale:
Selective serotonin reuptake inhibitors (SSRIs) generally do not require routine laboratory
monitoring because they do not have a narrow therapeutic index and do not typically cause
predictable laboratory abnormalities. Clinical monitoring focuses on therapeutic response,
adverse effects, mood changes, and suicide risk rather than laboratory values.
Option A is incorrect because routine complete blood count monitoring is not indicated for SSRI
therapy. Option B is incorrect because therapeutic serum drug levels are not routinely measured
with SSRIs unlike medications such as lithium. Option C is incorrect because SSRIs do not
routinely require blood glucose monitoring unless the client has a concurrent endocrine disorder
such as diabetes mellitus.
NCLEX Focus: Safe administration and monitoring of antidepressant medications.
DIF: Knowledge
REF: Psychopharmacology / SSRIs
OBJ: Identify monitoring requirements for SSRI therapy
TOP: Pharmacological Therapies
Chemical dependency assessment is integral to the initial assessment of chronic pain.
Which of the following raises a "red flag" about potential chemical dependency?
A. Use of more than one drug to treat the pain
B. Multiple times when prescriptions are lost with requests to refill
C. Preferences for treatments that include alternative medicines
D. Presence of a family member who has abused drugs
Correct Answer: B. Multiple times when prescriptions are lost with requests to refill
Expert Rationale:
Repeated reports of lost prescriptions accompanied by requests for early refills are considered
significant warning signs for possible substance misuse, diversion, or chemical dependency. This
behavior may indicate inappropriate medication use patterns and requires further assessment,
careful documentation, and monitoring by the healthcare provider.
Option A is incorrect because multimodal pain management using more than one medication is
common in chronic pain treatment. Option C is incorrect because interest in complementary or
alternative therapies does not indicate dependency risk. Option D is incorrect because a family
,history of substance abuse may increase risk but is not as strong an immediate behavioral red
flag as repeated lost prescriptions.
NCLEX Focus: Recognition of behaviors associated with substance misuse and dependency.
DIF: Application
REF: Pain Management / Substance Use Assessment
OBJ: Identify signs of potential chemical dependency
TOP: Psychosocial Integrity
Prescribing for women during their childbearing years requires constant awareness of the
possibility of:
A. Pregnancy unless the women is on birth control
B. Risk for silent bacterial or viral infections of the genitalia
C. High risk for developmental disorders in their infants
D. Decreased risk for abuse during this time
Correct Answer: B. Risk for silent bacterial or viral infections of the genitalia
Expert Rationale:
Women of childbearing age may have asymptomatic bacterial or viral genital infections that can
affect medication selection, reproductive health, pregnancy outcomes, and transmission risk.
Healthcare providers must consider undiagnosed infections when prescribing medications and
performing reproductive health assessments.
Option A is incorrect because pregnancy remains possible even with some forms of birth control
due to potential contraceptive failure. However, this option is not the best answer for the
question presented. Option C is incorrect because not all women of childbearing age are at
inherently high risk for developmental disorders in infants. Option D is incorrect because women
in childbearing years are not at decreased risk for abuse.
NCLEX Focus: Considerations in prescribing medications for women of reproductive age.
DIF: Application
REF: Women’s Health / Prescribing Considerations
OBJ: Recognize factors affecting medication prescribing in women
TOP: Health Promotion and Maintenance
First-line therapy for hyperlipidemia is:
A. Statins
B. Niacin
C. Lifestyle changes
D. Bile acid-binding resins
, Correct Answer: C. Lifestyle changes
Expert Rationale:
Lifestyle modifications are the first-line intervention for hyperlipidemia and include dietary
changes, weight management, smoking cessation, increased physical activity, and reduction of
saturated fat intake. These interventions can significantly improve lipid profiles and reduce
cardiovascular risk before medication therapy is initiated.
Option A is incorrect because statins are commonly prescribed when lifestyle modifications
alone are insufficient or when cardiovascular risk is elevated. Option B is incorrect because
niacin is not considered first-line therapy due to adverse effects and limited routine use. Option
D is incorrect because bile acid-binding resins are generally used as adjunctive therapy rather
than initial treatment.
NCLEX Focus: Nonpharmacologic management of hyperlipidemia.
DIF: Knowledge
REF: Lipid Management / Lifestyle Modification
OBJ: Identify first-line treatment strategies for hyperlipidemia
TOP: Health Promotion and Maintenance
The DEA:
A. Registers manufacturers and prescribes controlled substances
B. Regulates NP prescribing at the state level
C. Sanctions providers who prescribe drugs off-label
D. Provides prescribers with a number they can use for insurance billing
Correct Answer: A. Registers manufacturers and prescribes controlled substances
Expert Rationale:
The Drug Enforcement Administration (DEA) is responsible for regulating and monitoring
controlled substances in the United States. The DEA registers manufacturers, distributors, and
qualified prescribers authorized to prescribe controlled substances and enforces federal
controlled substance laws to prevent misuse and diversion.
Option B is incorrect because nurse practitioner prescribing authority is regulated primarily at
the state level by state boards of nursing and legislation, not by the DEA. Option C is incorrect
because off-label prescribing is generally legal and regulated through professional standards
rather than DEA sanctions. Option D is incorrect because DEA numbers are used for controlled
substance prescribing, not for insurance billing purposes.
NCLEX Focus: Legal and regulatory aspects of controlled substance prescribing.
for the use of beta blockers include:
A. Heart failure
B. Angina
C. MI
D. Dyslipidemia
Correct Answer: C. MI
Expert Rationale:
Beta blockers are strongly indicated following a myocardial infarction (MI) because they
decrease myocardial oxygen demand, reduce heart rate and blood pressure, and lower the risk of
reinfarction and sudden cardiac death. Beta blockade improves survival outcomes after MI by
reducing cardiac workload and preventing dysrhythmias.
Option A is incorrect because although certain beta blockers are used in heart failure
management, not all cases of heart failure universally require beta blockade as a primary
compelling indication. Option B is incorrect because beta blockers may be used for angina
symptom control, but MI remains the strongest evidence-based compelling indication in this
question. Option D is incorrect because beta blockers are not first-line agents for dyslipidemia
and may negatively affect lipid profiles in some clients.
NCLEX Focus: Pharmacologic management of cardiovascular disorders.
DIF: Knowledge
REF: Cardiovascular Pharmacology / Beta Blockers
OBJ: Identify compelling indications for beta-blocker therapy
TOP: Pharmacological Therapies
When a patient is on selective-serotonin reuptake inhibitors:
A. The complete blood count must be monitored every three to four months
B. Therapeutic blood levels must be monitored every six months after a steady state is achieved.
,C. Blood glucose must be monitored every three to four months.
D. There is no laboratory monitoring required.
Correct Answer: D. There is no laboratory monitoring required.
Expert Rationale:
Selective serotonin reuptake inhibitors (SSRIs) generally do not require routine laboratory
monitoring because they do not have a narrow therapeutic index and do not typically cause
predictable laboratory abnormalities. Clinical monitoring focuses on therapeutic response,
adverse effects, mood changes, and suicide risk rather than laboratory values.
Option A is incorrect because routine complete blood count monitoring is not indicated for SSRI
therapy. Option B is incorrect because therapeutic serum drug levels are not routinely measured
with SSRIs unlike medications such as lithium. Option C is incorrect because SSRIs do not
routinely require blood glucose monitoring unless the client has a concurrent endocrine disorder
such as diabetes mellitus.
NCLEX Focus: Safe administration and monitoring of antidepressant medications.
DIF: Knowledge
REF: Psychopharmacology / SSRIs
OBJ: Identify monitoring requirements for SSRI therapy
TOP: Pharmacological Therapies
Chemical dependency assessment is integral to the initial assessment of chronic pain.
Which of the following raises a "red flag" about potential chemical dependency?
A. Use of more than one drug to treat the pain
B. Multiple times when prescriptions are lost with requests to refill
C. Preferences for treatments that include alternative medicines
D. Presence of a family member who has abused drugs
Correct Answer: B. Multiple times when prescriptions are lost with requests to refill
Expert Rationale:
Repeated reports of lost prescriptions accompanied by requests for early refills are considered
significant warning signs for possible substance misuse, diversion, or chemical dependency. This
behavior may indicate inappropriate medication use patterns and requires further assessment,
careful documentation, and monitoring by the healthcare provider.
Option A is incorrect because multimodal pain management using more than one medication is
common in chronic pain treatment. Option C is incorrect because interest in complementary or
alternative therapies does not indicate dependency risk. Option D is incorrect because a family
,history of substance abuse may increase risk but is not as strong an immediate behavioral red
flag as repeated lost prescriptions.
NCLEX Focus: Recognition of behaviors associated with substance misuse and dependency.
DIF: Application
REF: Pain Management / Substance Use Assessment
OBJ: Identify signs of potential chemical dependency
TOP: Psychosocial Integrity
Prescribing for women during their childbearing years requires constant awareness of the
possibility of:
A. Pregnancy unless the women is on birth control
B. Risk for silent bacterial or viral infections of the genitalia
C. High risk for developmental disorders in their infants
D. Decreased risk for abuse during this time
Correct Answer: B. Risk for silent bacterial or viral infections of the genitalia
Expert Rationale:
Women of childbearing age may have asymptomatic bacterial or viral genital infections that can
affect medication selection, reproductive health, pregnancy outcomes, and transmission risk.
Healthcare providers must consider undiagnosed infections when prescribing medications and
performing reproductive health assessments.
Option A is incorrect because pregnancy remains possible even with some forms of birth control
due to potential contraceptive failure. However, this option is not the best answer for the
question presented. Option C is incorrect because not all women of childbearing age are at
inherently high risk for developmental disorders in infants. Option D is incorrect because women
in childbearing years are not at decreased risk for abuse.
NCLEX Focus: Considerations in prescribing medications for women of reproductive age.
DIF: Application
REF: Women’s Health / Prescribing Considerations
OBJ: Recognize factors affecting medication prescribing in women
TOP: Health Promotion and Maintenance
First-line therapy for hyperlipidemia is:
A. Statins
B. Niacin
C. Lifestyle changes
D. Bile acid-binding resins
, Correct Answer: C. Lifestyle changes
Expert Rationale:
Lifestyle modifications are the first-line intervention for hyperlipidemia and include dietary
changes, weight management, smoking cessation, increased physical activity, and reduction of
saturated fat intake. These interventions can significantly improve lipid profiles and reduce
cardiovascular risk before medication therapy is initiated.
Option A is incorrect because statins are commonly prescribed when lifestyle modifications
alone are insufficient or when cardiovascular risk is elevated. Option B is incorrect because
niacin is not considered first-line therapy due to adverse effects and limited routine use. Option
D is incorrect because bile acid-binding resins are generally used as adjunctive therapy rather
than initial treatment.
NCLEX Focus: Nonpharmacologic management of hyperlipidemia.
DIF: Knowledge
REF: Lipid Management / Lifestyle Modification
OBJ: Identify first-line treatment strategies for hyperlipidemia
TOP: Health Promotion and Maintenance
The DEA:
A. Registers manufacturers and prescribes controlled substances
B. Regulates NP prescribing at the state level
C. Sanctions providers who prescribe drugs off-label
D. Provides prescribers with a number they can use for insurance billing
Correct Answer: A. Registers manufacturers and prescribes controlled substances
Expert Rationale:
The Drug Enforcement Administration (DEA) is responsible for regulating and monitoring
controlled substances in the United States. The DEA registers manufacturers, distributors, and
qualified prescribers authorized to prescribe controlled substances and enforces federal
controlled substance laws to prevent misuse and diversion.
Option B is incorrect because nurse practitioner prescribing authority is regulated primarily at
the state level by state boards of nursing and legislation, not by the DEA. Option C is incorrect
because off-label prescribing is generally legal and regulated through professional standards
rather than DEA sanctions. Option D is incorrect because DEA numbers are used for controlled
substance prescribing, not for insurance billing purposes.
NCLEX Focus: Legal and regulatory aspects of controlled substance prescribing.
